High-molecular mucopolysaccharide, which affects the metabolic processes in the hyaline cartilage. The drug has chondroprotektivnym, stimulating the regeneration of cartilaginous tissue, anti-inflammatory effect. Participates in the construction of the main substance of cartilage and bone tissue, improves phosphoric-calcium metabolism in the cartilaginous tissue, inhibits enzymes that disrupt the structure and function of articular cartilage, inhibits the processes of degeneration of cartilaginous tissue.Stimulates the synthesis of proteoglycans, normalizes the metabolism of hyaline cartilage, promotes the regeneration of cartilaginous surfaces and the articular bag. Warns compression of connective tissue, increases the production of synovial fluid and mobility of affected joints, reduces concomitant inflammation, soreness, helps reduce the need for NSAIDs. With degenerative changes, cartilage tissue is a means of substitution therapy.
The positive effect is observed already in 2-3 weeks after the beginning of the drug administration: pain in the joints decreases, the clinical manifestations of the reactive synovitis disappear, the volume of movements in the affected joints increases. The therapeutic effect persists for a long time (3-6 months) after the end of the course of treatment.